Literature DB >> 9928827

No increased incidence of Alzheimer's disease in elderly schizophrenics.

K A Jellinger1, E Gabriel.   

Abstract

There is currently controversy as to the morphological basis of cognitive impairment in elderly schizophrenics. In contrast to previous findings, recent studies have found no increased frequency of Alzheimer's disease (AD) pathology in elderly schizophrenics. We examined 99 consecutive autopsy cases of patients over the age of 55 years from a psychiatric hospital who met the DSM-III-R and ICD.10 criteria for schizophrenia (mean age 69.5 +/- 8.25 years; mean duration of illness 35.15 +/- 10.1 years), 56% showing moderate to severe dementia. All brains were blindly reviewed for evidence of AD using CERAD criteria and Braak staging of neuritic AD lesions. "Definite" AD (CERAD C, Braak stage V) was seen in 2 cases aged 56 and 67 years, respectively [2% of total or 1/68 (1.4%) of those over age 65]. "Probable" AD (CERAD B, Braak stages IV-V) were seen in 5 cases aged 71-89 years (mean 79 years; 5% of total or 7.3% of those over age 65), and 1 case each with multiple cerebral infarcts and with Parkinson's disease pathology. In addition, 2 females aged 82 and 89 years, respectively, revealed senile dementia with tangles (NIA, CERAD negative; Braak stage IV), 1 with hippocampal sclerosis. The total incidence of definite and probable AD in this cohort was 7.1% or 8.7% for those over age 65. This is in line with other recent studies showing that the frequency of AD in elderly schizophrenics may be equal or even less than in the general population. The reasons for this negative association and the basis of cognitive deficits in elderly schizophrenics--those with dementia usually showing significantly lower brain weight--await further elucidation.

Entities:  

Mesh:

Year:  1999        PMID: 9928827     DOI: 10.1007/s004010050969

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 2.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

3.  Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia.

Authors:  Annapaola Prestia; Enrica Cavedo; Marina Boccardi; Cristina Muscio; Andrea Adorni; Cristina Geroldi; Matteo Bonetti; Paul M Thompson; Giovanni B Frisoni
Journal:  Am J Geriatr Psychiatry       Date:  2014-01-22       Impact factor: 4.105

4.  Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders.

Authors:  Shigeto Nagao; Osamu Yokota; Chikako Ikeda; Naoya Takeda; Hideki Ishizu; Shigetoshi Kuroda; Koichiro Sudo; Seishi Terada; Shigeo Murayama; Yosuke Uchitomi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-23       Impact factor: 5.270

Review 5.  What happens in the brain of schizophrenia patients?: an investigation from the viewpoint of neuropathology.

Authors:  Shuji Iritani
Journal:  Nagoya J Med Sci       Date:  2013-02       Impact factor: 1.131

6.  Neuropsychology, autobiographical memory, and hippocampal volume in "younger" and "older" patients with chronic schizophrenia.

Authors:  Christina Josefa Herold; Marc Montgomery Lässer; Lena Anna Schmid; Ulrich Seidl; Li Kong; Iven Fellhauer; Philipp Arthur Thomann; Marco Essig; Johannes Schröder
Journal:  Front Psychiatry       Date:  2015-04-21       Impact factor: 4.157

Review 7.  The dementias of schizophrenia.

Authors:  Ricardo de Oliveira-Souza; Rogério Paysano Marrocos; Jorge Moll
Journal:  Dement Neuropsychol       Date:  2007 Apr-Jun

Review 8.  Schizophrenia and risk of dementia: a meta-analysis study.

Authors:  Laisheng Cai; Jingwei Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-13       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.